HUP0001991A3 - Vaccines against varicella zoster virus gene 63 product - Google Patents

Vaccines against varicella zoster virus gene 63 product

Info

Publication number
HUP0001991A3
HUP0001991A3 HU0001991A HUP0001991A HUP0001991A3 HU P0001991 A3 HUP0001991 A3 HU P0001991A3 HU 0001991 A HU0001991 A HU 0001991A HU P0001991 A HUP0001991 A HU P0001991A HU P0001991 A3 HUP0001991 A3 HU P0001991A3
Authority
HU
Hungary
Prior art keywords
product
zoster virus
vaccines against
virus gene
varicella zoster
Prior art date
Application number
HU0001991A
Other languages
English (en)
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602617.4A external-priority patent/GB9602617D0/en
Priority claimed from GBGB9626882.6A external-priority patent/GB9626882D0/en
Application filed by Univ Liege filed Critical Univ Liege
Publication of HUP0001991A2 publication Critical patent/HUP0001991A2/hu
Publication of HUP0001991A3 publication Critical patent/HUP0001991A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HU0001991A 1996-02-09 1997-02-04 Vaccines against varicella zoster virus gene 63 product HUP0001991A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9602617.4A GB9602617D0 (en) 1996-02-09 1996-02-09 Vaccines
GBGB9626882.6A GB9626882D0 (en) 1996-12-24 1996-12-24 Vaccines
PCT/EP1997/000520 WO1997028820A1 (en) 1996-02-09 1997-02-04 Vaccines against varicella zoster virus gene 63 product

Publications (2)

Publication Number Publication Date
HUP0001991A2 HUP0001991A2 (hu) 2000-10-28
HUP0001991A3 true HUP0001991A3 (en) 2003-08-28

Family

ID=26308641

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001991A HUP0001991A3 (en) 1996-02-09 1997-02-04 Vaccines against varicella zoster virus gene 63 product

Country Status (20)

Country Link
EP (1) EP0879060B1 (hu)
JP (1) JP2002504080A (hu)
KR (1) KR100365986B1 (hu)
CN (1) CN1210470A (hu)
AR (1) AR005750A1 (hu)
AT (1) ATE390146T1 (hu)
AU (1) AU723555B2 (hu)
BR (1) BR9707400A (hu)
CA (1) CA2245545C (hu)
CZ (1) CZ289971B6 (hu)
DE (1) DE69738597T2 (hu)
ES (1) ES2301175T3 (hu)
HU (1) HUP0001991A3 (hu)
IL (1) IL125440A (hu)
NO (1) NO983617L (hu)
NZ (1) NZ331164A (hu)
PL (1) PL188457B1 (hu)
TR (1) TR199801531T2 (hu)
TW (1) TW575427B (hu)
WO (1) WO1997028820A1 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011241A1 (en) * 1997-09-05 1999-03-11 Smithkline Beecham Biologicals S.A. Oil in water emulsions containing saponins
ES2273482T3 (es) * 1998-03-09 2007-05-01 Glaxosmithkline Biologicals S.A. Composiciones de vacunas combinadas.
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
EP1227840B1 (en) * 1999-11-03 2007-10-03 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
CA2400842C (en) 2000-02-23 2013-01-15 Smithkline Beecham Biologicals S.A. Novel compounds
EA020617B1 (ru) 2009-05-27 2014-12-30 Глаксосмитклайн Байолоджикалс С.А. Конструкции casb7439
KR101723605B1 (ko) * 2014-10-21 2017-04-07 진원생명과학 주식회사 대상포진 예방 및 치료용 dna 백신 조성물 및 이를 이용한 vzv 항원에 대한 t세포 활성화 방법
CN114891830B (zh) * 2022-04-02 2024-03-01 武汉博沃生物科技有限公司 基于水痘-带状疱疹病毒的重组表达载体、重组病毒及用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
ATE119939T1 (de) * 1989-06-27 1995-04-15 Smithkline Beecham Biolog Verbindungen.

Also Published As

Publication number Publication date
CA2245545C (en) 2008-12-30
KR19990082360A (ko) 1999-11-25
NO983617L (no) 1998-10-02
TW575427B (en) 2004-02-11
DE69738597T2 (de) 2008-07-24
IL125440A (en) 2002-02-10
CN1210470A (zh) 1999-03-10
DE69738597D1 (de) 2008-05-08
ATE390146T1 (de) 2008-04-15
CA2245545A1 (en) 1997-08-14
NO983617D0 (no) 1998-08-06
WO1997028820A1 (en) 1997-08-14
NZ331164A (en) 2000-02-28
EP0879060B1 (en) 2008-03-26
PL188457B1 (pl) 2005-02-28
TR199801531T2 (xx) 1998-10-21
CZ289971B6 (cs) 2002-05-15
PL328414A1 (en) 1999-01-18
HUP0001991A2 (hu) 2000-10-28
BR9707400A (pt) 2000-01-04
AR005750A1 (es) 1999-07-14
ES2301175T3 (es) 2008-06-16
AU723555B2 (en) 2000-08-31
EP0879060A1 (en) 1998-11-25
JP2002504080A (ja) 2002-02-05
CZ248698A3 (cs) 1998-12-16
IL125440A0 (en) 1999-03-12
KR100365986B1 (ko) 2003-02-20
AU1601297A (en) 1997-08-28

Similar Documents

Publication Publication Date Title
ZA945414B (en) DNA virus ribozymes
GB9210273D0 (en) Dna
HUP9901901A3 (en) Vaccines against hepatitis c
HU9603144D0 (en) Dna construct for effecting homologous recombination and uses thereof
AU3729393A (en) Boomerand DNA amplification
AU3491897A (en) Vaccines comprising synthetic genes
GB9415369D0 (en) Mutant virus
HUP0001991A3 (en) Vaccines against varicella zoster virus gene 63 product
IL114576A0 (en) Polynucleotide herpes virus vaccine
GB9304239D0 (en) Viral particles
IL122412A0 (en) Recombinant viral nucleic acids
AU4582899A (en) Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
GB9200944D0 (en) Blower unit
EP0736089A4 (en) THERMOSTABLE VARICELLA ZOSTER VIRUS
GB9420010D0 (en) Nucleic acids
AU1785597A (en) Immediate early HSV-2 viral protein ICP27 as vaccine
GB9322702D0 (en) Vaccines
GB9310842D0 (en) Gene identification
GB9322808D0 (en) Vaccines
GB9408064D0 (en) Nucleic acids
GB9226172D0 (en) Hsv2 gene
AU7386894A (en) Antisense oligonucleotides against herpes simplex virus types 1 and 2
ZA97971B (en) Varicella Zoster virus 1E 63 compositions.
GB9305710D0 (en) Viral vaccines
GB9324964D0 (en) Viral vaccines

Legal Events

Date Code Title Description
FC4A Lapse of provisional application due to refusal